JP2009520766A5 - - Google Patents

Download PDF

Info

Publication number
JP2009520766A5
JP2009520766A5 JP2008546456A JP2008546456A JP2009520766A5 JP 2009520766 A5 JP2009520766 A5 JP 2009520766A5 JP 2008546456 A JP2008546456 A JP 2008546456A JP 2008546456 A JP2008546456 A JP 2008546456A JP 2009520766 A5 JP2009520766 A5 JP 2009520766A5
Authority
JP
Japan
Prior art keywords
acetone
solvent
ethanol
iii
salt
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2008546456A
Other languages
English (en)
Japanese (ja)
Other versions
JP2009520766A (ja
JP5317702B2 (ja
Filing date
Publication date
Priority claimed from DE102005061624A external-priority patent/DE102005061624A1/de
Application filed filed Critical
Publication of JP2009520766A publication Critical patent/JP2009520766A/ja
Publication of JP2009520766A5 publication Critical patent/JP2009520766A5/ja
Application granted granted Critical
Publication of JP5317702B2 publication Critical patent/JP5317702B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2008546456A 2005-12-21 2006-12-20 4−(ベンゾイミダゾリルメチルアミノ)−ベンゾアミドの塩の改良された製造方法 Active JP5317702B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE102005061624.0 2005-12-21
DE102005061624A DE102005061624A1 (de) 2005-12-21 2005-12-21 Verbessertes Verfahren zur Herstellung von Salzen von 4-(Benzimidazolylmethylamino)-Benzamidinen
PCT/EP2006/070034 WO2007071743A1 (en) 2005-12-21 2006-12-20 Improved process for the preparation of the salts of 4-(benzimidazolylmethylamino)-benzamides

Publications (3)

Publication Number Publication Date
JP2009520766A JP2009520766A (ja) 2009-05-28
JP2009520766A5 true JP2009520766A5 (https=) 2013-03-21
JP5317702B2 JP5317702B2 (ja) 2013-10-16

Family

ID=37950582

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2008546456A Active JP5317702B2 (ja) 2005-12-21 2006-12-20 4−(ベンゾイミダゾリルメチルアミノ)−ベンゾアミドの塩の改良された製造方法

Country Status (23)

Country Link
US (1) US7880016B2 (https=)
EP (1) EP1968949B1 (https=)
JP (1) JP5317702B2 (https=)
KR (1) KR101411961B1 (https=)
CN (1) CN101346355B (https=)
AR (1) AR058571A1 (https=)
AT (1) ATE485279T1 (https=)
AU (1) AU2006326980B2 (https=)
BR (1) BRPI0620150A2 (https=)
CA (1) CA2632310C (https=)
CY (1) CY1111113T1 (https=)
DE (2) DE102005061624A1 (https=)
DK (1) DK1968949T3 (https=)
ES (1) ES2355045T3 (https=)
IL (1) IL192242A (https=)
NZ (1) NZ569636A (https=)
PL (1) PL1968949T3 (https=)
PT (1) PT1968949E (https=)
RU (1) RU2425827C2 (https=)
SI (1) SI1968949T1 (https=)
TW (1) TWI411608B (https=)
WO (1) WO2007071743A1 (https=)
ZA (1) ZA200804198B (https=)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030181488A1 (en) 2002-03-07 2003-09-25 Boehringer Ingelheim Pharma Gmbh & Co. Kg Administration form for the oral application of 3-[(2-{[4-(hexyloxycarbonylamino-imino-methyl)-phenylamino]-methyl}-1-methyl-1H-benzimidazol-5-carbonyl)-pyridin-2-yl-amino]-propionic acid ethyl ester and the salts thereof
DE10339862A1 (de) * 2003-08-29 2005-03-24 Boehringer Ingelheim Pharma Gmbh & Co. Kg 3-[(2-{[4-(Hexyloxycarbonylamino-imino-methyl)- phenylamino]-methyl}-1-methyl-1H-benzimidazol-5-carbonyl)-pyridin-2-yl-amino]-propionsäure-ethylester-Methansulfonat und dessen Verwendung als Arzneimittel
DE102005061623A1 (de) * 2005-12-21 2007-06-28 Boehringer Ingelheim Pharma Gmbh & Co. Kg Verbessertes Verfahren zur Herstellung von 4-(Benzimidazolylmethylamino)-Benzamidinen und deren Salzen
DE102006054005A1 (de) * 2006-11-16 2008-05-21 Boehringer Ingelheim Pharma Gmbh & Co. Kg Neue Polymorphe von 3-[(2-{[4-(Hexyloxycarbonylamino-imino-methyl)-phenylamino]-methyl}-1-methyl-1H-benzimidazol-5-carbonyl)-pyridin-2-yl-amino]-propionsäure-ethylester
US8173906B2 (en) * 2007-02-07 2012-05-08 Raytheon Company Environmental protection coating system and method
US7767589B2 (en) * 2007-02-07 2010-08-03 Raytheon Company Passivation layer for a circuit device and method of manufacture
RU2010143901A (ru) * 2008-03-28 2012-05-10 Бёрингер Ингельхайм Интернациональ Гмбх (De) Способ получения композиций дабигатрана для перорального введения
WO2009153214A1 (en) * 2008-06-16 2009-12-23 Boehringer Ingelheim International Gmbh Process for the manufacture of an intermediate in the synthesis of dabigatran
NZ588488A (en) * 2008-06-16 2012-08-31 Boehringer Ingelheim Int Method for producing an intermediate product of dabigatran etexilate
BRPI0915942A2 (pt) * 2008-07-14 2019-04-09 Boehringer Ingelheim International Gmbh método para produção de compostos medicinais contendo dabigatrana
JP2013510072A (ja) 2008-11-11 2013-03-21 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング 従来のワルファリン治療に対して安全性プロフィールが改善されたダビガトランエテキシレートまたはその塩を使用して血栓症を治療または予防するための方法
US8399678B2 (en) 2009-11-18 2013-03-19 Boehringer Ingelheim International Gmbh Process for the manufacture of dabigatran etexilate
JP2013521318A (ja) * 2010-03-08 2013-06-10 ラティオファルム ゲー・エム・ベー・ハー ダビガトランエテキシラートを含有する医薬組成物
WO2012077136A2 (en) * 2010-12-06 2012-06-14 Msn Laboratories Limited Process for the preparation of benzimidazole derivatives and its salts
EP2522662A1 (en) 2011-05-11 2012-11-14 Medichem, S.A. Dabigatran etexilate and related substances, processes and compositions, and use of the substances as reference standards and markers
EP2834224B1 (en) 2012-04-02 2018-06-06 MSN Laboratories Limited Process for the preparation of benzimidazole derivatives and salts thereof
EP2890692A1 (en) 2012-08-31 2015-07-08 Ranbaxy Laboratories Limited Process for the preparation of crystalline form i of methanesulfonate salt of dabigatran etexilate
US9399616B2 (en) 2012-10-22 2016-07-26 Boehringer Ingelheim International Gmbh Process for the manufacture of 4-aminobenzoamidine dihydrochloride
US10077251B2 (en) 2012-10-29 2018-09-18 Biophore India Pharmaceuticals Pvt. Ltd. Process for the synthesis of Dabigatran Etexilate and its intermediates
US9533971B2 (en) 2012-10-29 2017-01-03 Biophore India Pharmaceuticals Pvt. Ltd Process for the synthesis of dabigatran and its intermediates
CN103275065A (zh) * 2013-05-30 2013-09-04 上海同昌生物医药科技有限公司 一种新的生产达比加群酯的方法
EP2835370A1 (en) 2013-08-08 2015-02-11 Medichem, S.A. New crystals of dabigatran etexilate mesylate
JP6403865B2 (ja) 2014-07-03 2018-10-10 シャンハイ インスティテュート オブ ファーマシューティカル インダストリー ダビガトランエテキシラート中間体の製造方法及び中間体化合物
CN105461686A (zh) * 2014-08-25 2016-04-06 江苏豪森药业股份有限公司 制备高纯度甲磺酸达比加群酯晶型的方法
CN104987323B (zh) * 2015-07-10 2017-08-22 浙江美诺华药物化学有限公司 一种达比加群酯的制备方法

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6087380A (en) * 1949-11-24 2000-07-11 Boehringer Ingelheim Pharma Kg Disubstituted bicyclic heterocycles, the preparations and the use thereof as pharmaceutical compositions
PE121699A1 (es) * 1997-02-18 1999-12-08 Boehringer Ingelheim Pharma Heterociclos biciclicos disustituidos como inhibidores de la trombina
DE19743435A1 (de) * 1997-10-01 1999-04-08 Merck Patent Gmbh Benzamidinderivate
TWI248435B (en) * 1998-07-04 2006-02-01 Boehringer Ingelheim Pharma Benzimidazoles, the preparation thereof and their use as pharmaceutical compositions
US6248770B1 (en) * 1998-07-09 2001-06-19 Boehringer Ingelheim Pharma Kg Benzimidazoles having antithrombotic activity
DE19962329A1 (de) * 1999-12-23 2001-06-28 Boehringer Ingelheim Pharma Benzimidazole, deren Herstellung und deren Verwendung als Arzneimittel
US6451832B2 (en) * 1999-12-23 2002-09-17 Boehringer Ingelheim Pharma Kg Benzimidazoles with antithrombotic activity
KR101005716B1 (ko) * 2002-03-07 2011-01-05 베링거 잉겔하임 파르마 게엠베하 운트 코 카게 3-[(2-{[4-(헥실옥시카보닐아미노-이미노-메틸)-페닐아미노]-메틸}-1-메틸-1h-벤즈이미다졸-5-카보닐)-피리딘-2-일-아미노] 프로피온산 에틸에스테르의 경구 투여 형태
NL1026498C2 (nl) * 2004-06-24 2005-12-28 Free Lift B V Hellinglifteenheid met blokkeerinrichting en blokkeerinrichting bestemd voor hellinglifteenheid.
EP1609784A1 (de) * 2004-06-25 2005-12-28 Boehringer Ingelheim Pharma GmbH & Co.KG Verfahren zur Herstellung von 4-(Benzimidazolylmethylamino)-Benzamidinen
DE102005061623A1 (de) * 2005-12-21 2007-06-28 Boehringer Ingelheim Pharma Gmbh & Co. Kg Verbessertes Verfahren zur Herstellung von 4-(Benzimidazolylmethylamino)-Benzamidinen und deren Salzen

Similar Documents

Publication Publication Date Title
JP2009520766A5 (https=)
US9416097B2 (en) Crystalline minocycline base and processes for its preparation
EP3733717A2 (en) An improved process for the preparation of sugammadex
CN105418642B (zh) 一种含噻唑吡啶酮结构的甲基丙烯酸酯荧光单体及其制备方法
JP2011126894A5 (https=)
CN104961730A (zh) 托吡司他新晶型及其制备方法
CN102617410B (zh) 一种3,4,5,6-四卤代酚磺酞的纯化方法
JP5793134B2 (ja) ペリレンテトラカルボン酸ジイミド化合物を含有してなる有機半導体材料、及び有機半導体素子
CN104829590B (zh) 一种纯化曲格列汀的方法
CN102924474A (zh) 一种氯吡格雷硫酸氢盐晶型ⅰ的制备方法
CA2676443A1 (en) Atorvastatin calcium propylene glycol solvates
CN104774150B (zh) 一种双醋瑞因晶体及其制备方法
CN109535140A (zh) 一种基于肟酯与吲哚构建双吲哚取代二氢吡咯酮类衍生物的方法
CN104961676B (zh) 烟酰胺类衍生物的甲磺酸盐a晶型及其制备方法和应用
WO2017219768A1 (zh) 氯虫苯甲酰胺的多晶型及其制备方法
CN102070606A (zh) 一种雷利度胺a晶型新的制备方法
CN106397317A (zh) 1,2,3,4‑四氢喹啉化合物及其合成方法与应用
CN107011322A (zh) 一种高纯度脱氢苯基阿夕斯丁类化合物的制备纯化方法
CN103880693B (zh) 一种γ-氨基丁酸酯衍生物的合成方法
JP6474276B2 (ja) ピセノジチオフェン化合物、有機半導体材料、有機半導体層、有機半導体素子
CN104860864B (zh) 2‑羰基‑5‑炔基吡咯化合物的合成方法
CN104030977B (zh) 一种达比加群酯中间体的制备方法
CN103724323B (zh) 泊马度胺的制备方法
EP2542550A1 (en) Process for the direct preparation of malic acid salt of sunitinib
JP6310326B2 (ja) δ−バレロラクトンの製造方法